Pseudomonas aeruginosa lectin LecB impairs keratinocyte fitness by abrogating growth factor signalling by Landi, Alessia et al.
  
 University of Groningen
Pseudomonas aeruginosa lectin LecB impairs keratinocyte fitness by abrogating growth factor
signalling
Landi, Alessia; Mari, Muriel; Kleiser, Svenja; Wolf, Tobias; Gretzmeier, Christine; Wilhelm,





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Landi, A., Mari, M., Kleiser, S., Wolf, T., Gretzmeier, C., Wilhelm, I., ... Römer, W. (2019). Pseudomonas
aeruginosa lectin LecB impairs keratinocyte fitness by abrogating growth factor signalling. Life science
alliance, 2(6). https://doi.org/10.26508/lsa.201900422
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 11-12-2019
Research Article
Pseudomonas aeruginosa lectin LecB impairs
keratinocyte ﬁtness by abrogating growth factor
signalling
Alessia Landi1,2 , Muriel Mari3, Svenja Kleiser1,2,4, Tobias Wolf5, Christine Gretzmeier4, Isabel Wilhelm1,2,6,
Dimitra Kiritsi4 , Roland Thünauer1,2, Roger Geiger5 , Alexander Nystro¨m4, Fulvio Reggiori3, Julie Claudinon1,2,
Winfried Ro¨mer1,2,6
Lectins are glycan-binding proteins with no catalytic activity and
ubiquitously expressed in nature. Numerous bacteria use lectins
to efﬁciently bind to epithelia, thus facilitating tissue colonisa-
tion. Wounded skin is one of the preferred niches for Pseudo-
monas aeruginosa, which has developed diverse strategies to
impair tissue repair processes and promote infection. Here, we
analyse the effect of the P. aeruginosa fucose-binding lectin LecB
on human keratinocytes and demonstrate that it triggers events
in the host, upon binding to fucosylated residues on cell mem-
brane receptors, which extend beyond its role as an adhesion
molecule. We found that LecB associates with insulin-like growth
factor-1 receptor and dampens its signalling, leading to the arrest
of cell cycle. In addition, we describe a novel LecB-triggered
mechanism to down-regulate host cell receptors by showing
that LecB leads to insulin-like growth factor-1 receptor inter-
nalisation and subsequent missorting towards intracellular
endosomal compartments, without receptor activation. Overall,
these data highlight that LecB is a multitask virulence factor that,
through subversion of several host pathways, has a profound
impact on keratinocyte proliferation and survival.
DOI 10.26508/lsa.201900422 | Received 10 May 2019 | Revised 15 October
2019 | Accepted 16 October 2019 | Published online 15 November 2019
Introduction
Bacteria can use many different strategies to infect host cells. In all
cases, the initiation of an infection requires the recognition of
speciﬁc structures at the host cell plasma membrane. This is often
achieved by lectins, which bind to glycosylated residues on proteins
and/or lipids present on the cell surface, mediating the attachment
of the bacterium to the cell. Multivalency is an important feature of
most lectins. On one hand, multivalency increases the binding afﬁnity
and speciﬁcity of the lectin–glycan interaction (Dam & Brewer, 2010).
On the other hand, the binding of lectins to multiple cell surface
receptors can induce receptor clustering and plasma membrane
rearrangements, triggering their entry into the host (Ro¨mer et al, 2007;
Windschiegl et al, 2009; Pezeshkian et al, 2017).
Pseudomonas aeruginosa is a Gram-negative bacterium, ubiq-
uitously spread in nature. It is an opportunistic pathogen that can
cause severe infections, especially in immunocompromised indi-
viduals, because of its resistance to most of the available antibiotics
and its ability to form impenetrable bioﬁlms. Hence, it has been
classiﬁed in the “priority 1/critical” category of the World Health
Organisation global priority pathogens list (global PPL) of antibiotic-
resistant bacteria to promote the research and development of new
antibiotic treatments (World Health Organization, 2017).
It is frequently implicated in hospital-acquired infections, where
it has been reported to cause different types of infections. Wounded
skin, after traumatic injuries, surgery or burns, is one of the pref-
erentially targeted tissue by this bacterium, which has also been
associated with the delay and prevention of wound healing. The
presence of P. aeruginosa correlates in fact with a bad prognosis of
healing, and leads to the persistence of the inﬂammatory stage of the
wound healing process (Gjødsbøl et al, 2006; Bjarnsholt et al, 2007).
P. aeruginosa possesses two tetravalent lectins in its arsenal of
virulence factors, LecA and LecB (also called PA-IL and PA-IIL, re-
spectively). LecB is a tetramer, consisting of four monomers with
high speciﬁcity for L-fucose and its derivatives (Garber et al, 1987;
Gilboa-Garber et al, 2000). LecB production is regulated by rhl and
Pseudomonas quinolone signal, which are part of the quorum-sensing
systems (Winzer et al, 2000; Diggle et al, 2003). Once synthesised,
LecB is exposed on the outer bacterial membrane, where it has
been described to interact with the outer membrane porin OprF
(Tielker et al, 2005; Funken et al, 2012).
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The current assumption is that LecBmainly functions by promoting
the adhesion of P. aeruginosa to both the host cell and the exopo-
lysaccharide matrix, which encases bacterial cells together. However,
several in vitro and in vivo studies have shown LecB to act not only as
an adhesin but also as an important virulence factor, capable of
triggering additional host cell responses (Schneider et al, 2015;
Wilhelm et al, 2019). LecB has been reported to be a determinant of P.
aeruginosa cytotoxicity in lung epithelial cells and to block ciliary
beating in human airways (Adamet al, 1997; Chemani et al, 2009). LecB-
negative mutant bacteria exhibit an impaired bioﬁlm formation in
comparisonwith wild-type strains and no type VI pili assembly (Tielker
et al, 2005; Sonawane et al, 2006). Furthermore, LecB induces alveolar
capillary barrier injury in vivo, leading to a higher bacterial dissem-
ination into the bloodstream (Chemani et al, 2009). Previous studies
have reported additional effects of LecB in inhibiting cell migration
and proliferation (Cott et al, 2016). However, its precise mechanism of
action has not yet been elucidated and none of the existing studies
have addressed its role in skin infections.
Here, we report that the P. aeruginosa lectin LecB is present in
chronically infected human wounds, implying its contribution to the
persistence of wound infections. Moreover, we show that insulin-like
growth factor-1 receptor (IGF-1R) coprecipitates with LecB and that
LecB leads to IGF-1R internalisation and missorting towards in-
tracellular LC3-positive compartments. Notably, IGF-1R is internalised
without being activated. We further demonstrate that LecB blocks the
cell cycle and induces cell death, which is preceded by a strong
vacuolisation. These vacuoles, which possess peculiar morphological
features, originate from rufﬂe-like structures at subdomains of the
plasmamembranewhere LecB is enriched. Therefore, we propose that
LecB, in addition to play a role as an adhesion factor, both mis-
regulates growth factor receptor signalling and subverts the endocytic
system, leading to an impairment of vital keratinocyte functions.
Results
LecB is present in chronically infected human wounds
Although LecB is enriched in bioﬁlms, which often characterise
chronic wounds, no evidence had yet been provided showing its
presence in wounds. Before we addressed the effects of LecB on
human keratinocytes at a molecular level, we ﬁrst veriﬁed the
presence of LecB in infected human wounds. To this aim, we
collected chronically wounded tissue from patients infected with
P. aeruginosa, as shown by wound swabs. We stained the parafﬁn-
embedded tissue sections with an antibody against P. aeruginosa
to conﬁrm its presence in the wounds. As control, we used normal
skin samples. Indeed, we could detect the presence of P. aeru-
ginosa, either as bioﬁlm or in the form of small colonies (Fig 1A).
We subsequently speciﬁcally stained for LecB, and strikingly, we
found that this lectin was distributed in the wound sections, both
in the keratinocyte layers and in the dermis (Fig 1B). In contrast, no
LecB was detected in the normal skin control samples. This result
provides the ﬁrst evidence of LecB in chronic human wounds, with
superinfection possibly playing a role in the wound chronicity.
Figure 1. LecB localisation in chronically infected human wounds.
(A, B) Tissue sections of human infected wounds embedded in parafﬁn and stained for (A) P. aeruginosa (green) and for (B) LecB (green). Normal skin is used as negative
control. Note: green signal in the upper left panel (A) is due to unspeciﬁc staining in the stratum corneum, not present in wounds. Rectangular squares refer to the
zoomed area. Arrows point at LecB localised in the epidermal layers; arrowheads indicate LecB distributed in the dermis.
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LecB coprecipitates with essential plasmamembrane receptors in
normal human keratinocytes (NHKs)
Next, we moved to NHKs, the predominant cell type in the epi-
dermis, to study the mechanism of action of LecB in molecular
detail. LecB plays a crucial role in the adhesion of P. aeruginosa to
host cells (Chemani et al, 2009), implying the necessity for the lectin
to target plasma membrane receptors via their glycosylated resi-
dues. Therefore, we screened for potential LecB-interacting pro-
teins via a pull-down assay. Brieﬂy, we cultured NHKs in the
presence or absence of 5 μg/ml (106 nM) of biotinylated LecB, lysed
them under conditions that preserve protein–protein interactions
and incubated with streptavidin agarose beads to precipitate LecB
in complex with interacting proteins. Subsequently, we performed
on bead digestion and analysed the obtained peptides by protein
mass spectrometry. This analysis revealed the presence of im-
portant cell growth factor receptors within the enriched proteins in
the LecB pull-down fractions (Table S1). The protein mass spec-
trometry results were veriﬁed by Western blot and conﬁrmed the
presence of two of the major keratinocyte growth factor receptors
implicated in epidermal keratinocytes proliferation and migration,
IGF-1R, and the epidermal growth factor receptor 1 (EGFR) (Haase,
2003; Sadagurski et al, 2005) (Figs 2A, and S1A and B). In addition to
stimulating the cells with biotinylated LecB, an excess of L-fucose
(30 mM) was added to clarify whether the interaction of LecB with
IGF-1R or EGFR was carbohydrate dependent. As L-fucose saturates
the carbohydrate-binding pockets of LecB, no binding to cell
membranes could be detected when LecB and L-fucose were si-
multaneously applied to the cells, as neither IGF-1R nor EGFR could
be coprecipitated (Fig S1A and B). We further investigated in detail
the effect of LecB on IGF-1R because of its higher fold enrichment.
We hypothesised that LecB interaction with IGF-1R triggers receptor
internalisation. Indeed, surface staining experiments showed that
IGF-1R is depleted from the plasma membrane of keratinocytes in a
time-dependent manner as a consequence of LecB incubation (Fig
2B and C). Concurrently, we observed an intracellular redistribution
of the receptor, which accumulates in regions positive for the ly-
sosomal marker protein LAMP1 (Fig S1C). This observation correlated
with the strong increase of lysosomes upon treatment (Fig S1D) and
suggests that the receptor is targeted for degradation upon LecB.
However, lysosomal degradation inhibition with baﬁlomycin A1 only
partially restored IGF-1R levels (Fig S1E and F), indicating that LecB
can act on other degradative pathways.
IGF-1R internalisation from the plasma membrane was also
detectable after stimulation with 100 ng/ml of IGF-1 (Fig S2A and B).
However, whereas IGF-1 induced a fast autophosphorylation of the
receptor on multiple tyrosine residues (Tyr1135, Tyr1131, and
Tyr1136), LecB did not (Fig 2D–G). Thus, we conclude that LecB does
not lead to the activation of IGF-1R but rather triggers a “silent”
receptor internalisation.
LecB impairs cell survival signalling pathways and leads to cell
cycle arrest
Growth factor receptors activate two major downstream signalling
pathways, the mitogen-activated protein kinase/extracellular signal-
regulated kinase (MAPK/ERK) and the phosphatidylinositol 3-kinase-
protein kinase B (PI3K-AKT) cascade, which are responsible for inhi-
bition of apoptosis, and stimulation of both protein synthesis and cell
proliferation (Lemmon & Schlessinger, 2010; Mendoza et al, 2011).
Whereas the former ultimately results in the phosphorylation and
activation of extracellular signal-regulated kinase 1/2 (ERK1/2), the
latter activates the mammalian target of rapamycin (mTOR). To de-
termine whether these two signalling cascades were affected by LecB,
we monitored ERK1/2 and mTOR phosphorylation at Thr202/Tyr204
and Ser2448, respectively. The amounts of phosphorylated proteins
were normalised to the respective pan-proteins. Indeed, LecB did not
lead to the phosphorylation of both ERK1/2 and mTOR (Fig 3A–D).
ERK1/2 phosphorylation actually signiﬁcantly decreased 1 h post-
stimulation (Fig 3A and C). In contrast, LecB activated 59 adenosine
monophosphate–activated protein kinase (AMPK), a cellular energy
and nutrient status sensor, which is activated in response to cellular
energy depletion (Fig 3A and E). AMPK phosphorylation signiﬁcantly
increased 3 h post-stimulation and was inhibited by addition of
L-fucose, conﬁrming that this posttranslational modiﬁcation is
LecB dependent (Fig S3A and B).
The activation of AMPK correlates with the inhibition of ERK1/2
because the latter has been reported to negatively regulate the
phosphorylation of AMPK via the liver kinase B1 (LKB1) (Woods et al,
2003; Shaw et al, 2004). Furthermore, consistently with the in-
hibition of ERK1/2 activity, we observed a strong cyclin D1 degra-
dation (Fig 3F and G), which led to the arrest of cell cycle and, thus,
to the reduction of cell viability (Fig 3H). Interestingly, the cytotoxic
effect was preceded by an extensive cytoplasmic vacuolisation (Fig
3I). L-fucose supplementation rescued the phenotype and restored
cell viability (Fig 3H and I). Altogether, these observations elucidate
that LecB impairs a key mechanism that regulates cell survival and
proliferation, resulting in the blockage of cell cycle.
The cytotoxic effect of LecB is accompanied by the formation of
LecB-positive intraluminal vesicle-containing vacuoles
Next, we used transmission electron microscopy to further inves-
tigate the cellular vacuolisation triggered by LecB treatment. Un-
treated keratinocytes presented several light content vacuoles
(Category 1), corresponding to endo-lysosomal compartments (Fig
4A). In contrast, LecB-treated cells displayed numerous degradative
vesicles (Category 2) and an additional type of vacuoles (Category 3),
with irregular shapes and variable sizes (Fig 4B). Surprisingly, these
vacuoles contained a large number of clearly deﬁned intraluminal
vesicles (Fig 4B) and they appeared to cluster together to form an
intricate network (Fig 4B, zoom). To get insights into the origin of
these structures, we performed a time-course experiment by col-
lecting cells at different time points, from 30 min to 12 h after ex-
posure to LecB (Fig S4A–E9). The Category 3 vacuoles were detectable
after 30 min of LecB incubation, but they were quite rare. However,
they became more prominent 3 h post-LecB exposure (Fig S4D).
Interestingly, speciﬁc regions of the plasma membrane of the LecB-
treated keratinocytes were extremely irregular and characterised by
the presence of rufﬂe-like structures (Fig S4A–E). As the number of
Category 3 vesicles located at these regions increased over time, we
hypothesised that the intraluminal vesicle-containing vacuoles
originate from subdomains of the plasma membrane upon LecB
interaction with surface proteins. This hypothesis implies that LecB is
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Figure 2. LecB depletes IGF-1R from the plasma membrane without inducing its activation.
(A) Western blot of eluted samples from pull-down assay. NHKs were stimulated in the presence of 5 μg/ml biotinylated LecB (106 nM). The lysates were
incubated with streptavidin beads and further eluted. Western blot was performed and IGF-1R and LecB were detected in the precipitated fractions. (B, C) Surface
staining of keratinocytes treated with LecB (5 μg/ml) for the indicated time points. (B) Images show maximum intensity projections. After stimulation, the cells
were stained for IGF-1R (red) and DAPI (blue). Scale bar: 10 μm. (C) Quantiﬁcation of IGF-1R surface intensity from n = 4 independent experiments. Bars display
the mean value ± SEM. ** denotes P < 0.01; **** denotes P < 0.0001; one-way ANOVA was used for statistical analysis. (D) Representative blots from lysates after
LecB (5 μg/ml) and IGF-1 (100 ng/ml) stimulation for the indicated times. Antibodies against different phosphorylation sites of IGF-1R (Tyr1131 and Tyr1135/1136)
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present in theCategory 3 vacuoles. To test this, weexposedkeratinocytes
to biotinylated LecB before performing immunoelectron microscopy
(IEM) using anti-biotin antibodies (Fig 4C–F). Notably, we speciﬁcally
detected LecBonboth the limitingmembraneof the Category 3 vacuoles
and to a minor extent on their intraluminal vesicles (Fig 4D). Moreover,
we also identiﬁed biotinylated LecB at the plasma membrane, where it
was especially enriched in the rufﬂe-like regions (Fig 4F), supporting the
notion that LecB drives the formation of a plethora of intracellular
vesicles originating from the plasma membrane.
LecB is trafﬁcked towards an endocytic degradative route
Next, we proceeded to characterise the intracellular LecB-positive
vacuoles detected by IEM in immunoﬂuorescence experiments,
where keratinocytes exposed to ﬂuorescently labelled LecB were
stained with antibodies recognising different organelle marker
proteins. We found a time-dependent colocalisation of LecB with
microtubule-associated proteins 1A/B light chain 3B (LC3) and ras-
related protein Rab-9A (RAB9A), which are generally enriched on
autophagosomes and late endosomes, respectively (Fig 5A and B).
Moreover, but to a minor extent, we also observed a time-dependent
colocalisation between LecB and lysosomal-associated membrane
glycoprotein 1 (LAMP1) (Fig S5A). In contrast, no colocalisation with the
recycling endosomemarker protein ras-related protein Rab-11 (RAB11)
was detected (Fig S5B). Endocytosis and internalisation of LecB was
also assessed biochemically by analysing the ubiquitination of the
proteins associated with LecB, as a large number of growth factor
receptors undergo ubiquitination upon endocytosis (Sehat et al, 2008;
Haglund & Dikic, 2012). In a time-course pull-down experiment, we
detected a decrease of the coprecipitated levels of IGF-1R and an
increase of the ubiquitin levels in the eluted fraction, indicating that
LecB-interacting partners are ubiquitinated, thus very likely intern-
alised (Fig 5C and D).
Taken together, these results demonstrate that LecB is trafﬁcked
towards degradative compartments and suggest that ubiquitin may
be the endocytic signal for the degradation of IGF-1R and poten-
tially other LecB-interacting partners.
LAP participates in targeting LecB–IGF–1R complexes to
degradation
As we saw a time-dependent increase in colocalisation between
LC3 and LecB structures (Fig 5A), we decided to investigate this
further. LC3 is an ubiquitin-like protein that upon autophagy in-
duction is converted from a cytoplasmic form (i.e., LC3-I) to one
associated with the autophagosomal membranes (i.e., LC3-II)
through conjugation to phosphatidylethanolamine (Kabeya et al,
2004). LC3-II can also be generated on the limiting membrane of
endosomes during processes such as LC3-associated phagocytosis
(LAP) (Sanjuan et al, 2007; Florey et al, 2011). The fact that LecB was
detected on single-membrane vacuoles (autophagosomes are
double-membrane vesicles with cytoplasmic content) that are
positive for RAB9 (Figs 4D and 5B), inferred in an activation of LAP-
like pathway. Although induction of both autophagy and LAP induces
the formation of LC3-II, only autophagy leads to the degradation of
this conjugate (Tanida et al, 2005). Indeed, we observed a time-
dependent increase of LC3-II levels upon exposure of keratinocytes
to LecB (Fig 6A and B). However, this protein was not turned over
because no difference in LC3-II levels could be observed when
LecB-treated keratinocytes were incubated with either baﬁlomycin
A1 or cycloheximide to assess LC3-II stability (Fig S6A–D). To clarify
the origin of LC3-II, we silenced ATG13 (Fig S6E and F), an essential
component of the ULK kinase complex, which is required for mac-
roautophagy (Ganley et al, 2009) and dispensable for LAP (Florey et al,
2011; Martinez et al, 2011). Our results revealed that LC3-II formation
upon cell treatment with LecB is ATG13 independent (Fig S6E and G).
Furthermore, whenwe performed LecB treatment in combination with
cytochalasin D, an inhibitor of actin polymerization, we found a de-
crease in LecB uptake (Fig S7A andB), indicating that actin is important
for LecB internalisation.
Next, we investigated whether IGF-1R also colocalised with LC3-
positive vesicles. Indeed, we found colocalisation between IGF-1R,
LC3, and LecB (Fig 6C), but interestingly, we did not observe LC3
recruitment onto membranes when cells were treated exclusively
with IGF-1 (Fig S8). Finally, we examined another receptor, the
transferrin receptor (TfR), which was not pulled down by LecB (Fig
S9). Unlike IGF-1R and other growth factor receptors, which can be
internalised via clathrin-independent mechanisms (Boucrot et al,
2015), TfR enters the cells via clathrin-mediated endocytosis and it
is recycled back to the plasma membrane upon iron delivery
(Hopkins & Trowbridge, 1983). Interestingly, whereas we observed
colocalisation between IGF-1R and LC3 (Fig 6D), we did not detect
changes in TfR distribution nor LC3 colocalisation upon LecB
treatment (Fig 6E). This is supported by the absence of colocali-
sation between LecB and RAB11 compartments as well (Fig S5B) and
suggests that LecB preferentially commits receptors to degrada-
tion, thereby affecting their signalling.
Taken together, these results demonstrate that LC3 recruitment
onto LecB–IGF–1R complex–positive endosomes is independent
from macroauthophagy.
Discussion
Bacterial lectins have predominantly been described as adhesion
proteins, which promote the attachment of bacteria to cell plasma
membrane through their interaction with host cell surface glycans
(Sharon, 1987). This study provides new insights into the role of P.
aeruginosa lectin LecB as virulence factor that impairs growth
factor receptor signalling and trafﬁcking, thereby affecting kerati-
nocyte ﬁtness. Pull-down studies showed the co-isolation of LecB
with several plasma membrane receptors in keratinocytes, among
which IGF-1R and EGFR were two of the principal interactors. We
further demonstrated that LecB depletes IGF-1R from the plasma
and against total IGF-1R were used. Tubulin was used as loading control. (E, F, G) Blot quantiﬁcation. Phosphorylated IGF-1R (E, F) and total IGF-1R levels (G) are
represented as fold change compared with the loading control from n = 3 independent experiments. * denotes P < 0.05; *** denotes P < 0.001; two-way ANOVA was
used for statistical analysis.
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membrane by inducing its internalisation. To modulate signalling,
IGF-1R (as well as EGFR) needs to be activated by ligand binding and
consequent autophosphorylation on three tyrosine residues (i.e.,
Tyr1135, Tyr1131, and Tyr1136) in its C-terminal tail (Favelyukis et al,
2001; Sousa et al, 2012). Interestingly, unlike IGF-1, LecB triggers IGF-1R
endocytic trafﬁcking towards degradative compartments without
receptor activation.
PI3K/AKT and MAPK/ERK signalling cascades have been in-
tensively investigated for their role in promoting cell and organ-
ismal growth upon growth factor signals. This is mainly achieved
by AKT-mediated activation of mTOR, which is a key regulator of
anabolic processes necessary during cell growth (Nave et al, 1999;
Dennis et al, 2001) and by the phosphorylation of ERK1/2, which
results in cell proliferation (Rossomando et al, 1991; Meloche &
Pouysse´gur, 2007). We found that neither mTOR nor ERK1/2 is ac-
tivated upon cell exposure to LecB. Speciﬁcally, we observed a de-
crease in the levels of phospho-ERK1/2 after 1 h of LecB treatment,
which correlates with an increase of phospho-AMPK. Reciprocal
feedback loops have been described to operate between the AMPK
and the MAPK/ERK pathways and, whereas ERK1/2 activation was
reported to be attenuated upon stimulation of WT MEFs with the
AMPK activator A-769662, little effect on ERK1/2 phosphorylation was
detected when AMPK-null MEFs were used (Zheng et al, 2009; Shen
et al, 2013). The suppression of cell survival signalling pathways
can also clarify the arrest of the cell cycle in the G1/S transition
observed upon LecB incubation. ERK1/2 activity is in fact required for
both the cell cycle entry and the suppression of negative cell cycle
regulators. Speciﬁcally, cyclin D1 expression is enhanced by the
activation of the MAPK/ERK pathway (Lavoie et al, 1996; Weber et al,
1997), via the transcription factors c-Fos (Burch et al, 2004) and Myc
(Seth et al, 1991). Cells, entering into the S phase show low levels of
cyclin D1, which is again induced and reaches high levels to ensure
the progression into the G2 phase (Yang et al, 2006). LecB stimulation
mediates a strong reduction of cyclin D1, whose levels are not re-
stored over time, resulting in the arrest of the cell cycle and sub-
sequential induction of cell death. Therefore, we speculate that LecB,
despite devoid of catalytic activity, may contribute in promoting
tissue damage to facilitate bacterial dissemination and extracellular
multiplication during wound infections. Furthermore, it is possible
that LecB induces a similar fate to other cell types, including immune
cells, thus further promoting the infection. Future work will provide
new insights on the impact of LecB on the immune response during
chronic wound infections.
Interestingly, the cytotoxic effect of LecB was preceded by an
extensive cytoplasmic vacuolation. Electron microscopy inspection
of LecB-treated cells revealed the peculiar nature of these vacuoles
that accumulate over time and display an increased number of
intraluminal vesicles. We also show that these vacuoles probably
originate from rufﬂe-like plasma membrane regions where LecB
was also found to be enriched. In the case of other bacterial lectins,
such as the B-subunit of Shiga toxin (StxB) from Shigella dysen-
teriae and LecA from P. aeruginosa, the sole interaction with the
glycosphingolipid receptor globotriaosyl ceramide (Gb3) is sufﬁ-
cient to drive membrane shape changes leading to their sub-
sequent uptake (Ro¨mer et al, 2007; Eierhoff et al, 2014). In the case of
LecB, however, pull-down experiments point to the existence of
several receptors, also attributable to the fact that fucosylation is a
very common modiﬁcation. LecB exists as a tetramer and each
monomer possesses a binding pocket with the highest afﬁnity to
L-fucose and its derivatives (Garber et al, 1987; Sabin et al, 2006).
Although the L-fucose dissociation constant is in the micromolar
range (2.9 μM), an increase in avidity can be achieved by a higher
degree of interactions. This implies that LecB might crosslink
several different surface receptors, thus inducing a higher degree of
membrane rearrangements that could explain the extensive al-
terations at the plasma membrane. Moreover, multiple interactions
could provide the bacterium with additional resources for the
initiation of host tissue colonisation.
By following LecB trafﬁcking, we sought to characterise the
nature of LecB-mediated vacuoles, which, from a structural point of
view, shows similarities with multivesicular bodies, as they contain
numerous intraluminal vesicles. Immunoﬂuorescence experiments
revealed a time-dependent increase of colocalisation between
LecB and Rab-9, LC3, and LAMP-1. Therefore, our data indicate that
LC3 is recruited on LecB containing late endosomes, which may
further favour their lysosomal degradation through a process that
may be similar or identical to LAP. LAP can be triggered by several
receptors. In addition to toll-like receptors, whose signalling during
phagocytosis rapidly recruits LC3 to phagosomes, the phosphati-
dylserine receptor TIM4, or the C-type lectin dectin-1 can also in-
duce LAP to efﬁciently clear dead cells and to facilitate antigen
presentation, respectively (Sanjuan et al, 2007; Martinez et al, 2011;
Ma et al, 2012). LC3 can associate with single-membrane phagosomes
even in the absence of pathogens or dead cells, such in the case of
phagocytosis and degradation of photoreceptor outer segments by
retinal pigment epithelium or during the secretion of mucins in
goblet cells (Kim et al, 2013; Patel et al, 2013). Our data indicate that
IGF-1R colocalises with LecB and LC3, suggesting that LAP or an
LAP-like pathway is involved in IGF-1R sorting for degradation, after
LecB-induced receptor internalisation.
The current model describes that tyrosine kinase receptors, upon
ligand binding, are internalised and trafﬁcked to early endosomes.
Figure 3. LecB impairs cell survival signalling pathways and leads to cell cycle arrest.
(A, B, C, D, E) Representative blots and relative quantiﬁcations of N = 3 independent experiments. NHKs were treatedwith 5 μg/ml LecB for the indicated time and lysates
were subjected to SDS–PAGE and Western blot analysis using the designated anti-phospho (A) and anti-pan antibodies (B). GAPDH was added as loading control. Graphs
(C, D, E) depict the fold change of the phosphorylated protein compared with pan levels and represent themean value ± SEM. ** denotes P < 0.01, **** denotes P < 0.0001, ns
denotes not signiﬁcant; multiple t tests were used for statistical analysis. (F)Western blot showing cyclin D1 levels after 12 and 24 h of LecB stimulation (5 or 10 μg/ml).
(G) Quantiﬁcation of cyclin D1 relative to tubulin. The mean value ± SEM of N = 3 independent experiments is reported. * denotes P < 0.05, ** denotes P < 0.01; one-way
ANOVA was used for statistical analysis. (H) MTT assay assessing the cytotoxic effect of LecB. NHKs were treated with the indicated LecB concentration with or without
30mM L-fucose for 24 h. Staurosporine (1 μM) was used as positive control. MTT was added to themedium and left for 4 h. The absorbance at 570 nmwas measured and
plotted as fold change compared with the untreated or L-fucose–treated sample. The mean value ± SEM of N = 5 is plotted. ** denotes P < 0.01; one-way ANOVA was used
for statistical analysis. (I) Representative images of keratinocyte monolayers after 24-h exposure to 5 μg/ml LecB with or without 30 mM L-fucose. White arrows in the
zoomed image point at vacuolar structures induced by lectin treatment. Scale bar: 200 μm.
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From here, they can either be sorted to lysosomal degradation via
multivesicular bodies or they can be recycled back to the plasma
membrane. The equilibrium between IGF-1R degradation and recy-
cling is essential tomodulate receptor signalling (Morrione et al, 1997;
Monami et al, 2008). Our data demonstrate that IGF-1R trafﬁcking is
subverted upon cell treatment with LecB, which induces the sorting
of this receptor towards degradative routes, without activating it. We
do not know yet whether there is a direct or indirect interaction
between LecB and IGF-1R, despite being co-isolated as complex.
However, because IGF-1R is not the sole protein interacting with LecB
in keratinocytes, we speculate that this “targeting for degradation”
strategy can be valid for other plasma membrane receptors as well
Figure 4. The cytotoxic effect of LecB is preceded by the formation of intraluminal vesicle-containing vacuoles.
(A, B) NHKs were incubated with 5 μg/ml LecB and processed for conventional electron microscopy at 12 h post-incubation. (A, B) Representative electrographs of the
untreated (A) and LecB-treated (B) cells. Black hashtags point at Category 1 vacuoles, whereas black and red asterisks indicate Category 2 and Category 3 vacuoles, respectively.
Zoomed image of panel (B) shows a higher magniﬁcation of the Category 3 vacuoles containing intraluminal vesicles. Scale bars: 1 μm. (C, D, E, F) Cells treated with 5 μg/ml
biotinylated LecB or un-tagged LecB for 12hwere subjected to immuno-EM. (C, E) Control staining showing no aspeciﬁc antibodybinding. (D) LecB localises in internal vesicles,
either in the lumen (panel [D] zoom, black arrowheads) or at the limitingmembrane (white arrowheads). (F) LecB localisation at the plasmamembrane, in the rufﬂe-like region.
Scale bars: 500 nm. Scalebar zoompanel (D): 200 nm. E, endosome; ER, endoplasmic reticulum; G, Golgi apparatus; k, keratin;M,mitochondrion;N, nucleus; PM, plasmamembrane.
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(e.g., EGFR) and that it can be used by P. aeruginosa to silence host
cell receptors to favour tissue colonisation in wounds.
Wound infections represent a socioeconomic burden for the
health care system and, given that P. aeruginosa is very hard to
eliminate with the available antibiotics, there is urgent need for the
development of alternative therapeutic strategies (Norberg et al,
2017; Sommer et al, 2018). Our ﬁndings shed new light on the P.
aeruginosa lectin LecB, showing that it is capable of inducing a
succession of cellular events, despite being devoid of catalytic
activity and by virtue of its sole capability to bind to sugar moieties
on the plasma membrane. This knowledge paves the way for a
better understanding of P. aeruginosa wound infections.
Materials and Methods
Antibodies, inhibitors, and activators
Used antibodies are listed in Tables S2 and S3. Aprotinin (0.8 μM),
leupeptin (11 μM), and pefabloc (200 μM), used as protease inhibitors,
Figure 5. LecB localises in LC3- and RAB9-positive compartments.
(A, B) Confocal micrographs with respective colocalisation quantiﬁcation of keratinocytes stimulated with 5 μg/ml of ﬂuorescently labelled LecB (green). Panels indicated as
“+LecB” refer to 12 h incubation. (A, B) After ﬁxation and permeabilisation, the cells were stained for LC3 (A) and RAB9 (B) (both in red). Graphs report the mean value ± SEM of
Mander’s overlap coefﬁcients calculated from at least three independent experiments. **** denotes P < 0.0001; one-way ANOVAwas used for statistical analysis. Scale bar: 10μm.
(C, D)Westernblot of eluted samples from time series pull-down assays usingbiotinylated LecB (5μg/ml). (C, D)Membraneswereprobed for LecB, IGF-1R (C) andubiquitin (D).
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Figure 6. IGF-1R is sorted to degradation by LecB.
(A, B) NHKs were incubated with LecB (5 μg/ml) for the indicated time points and whole cell lysates were immunoblotted for LC3 and β-actin (A). (B) The levels of LC3-II
were normalised to β-actin and depicted as fold change increase to the untreated condition (B). Error bars indicate means ± SEM of N = 5 independent experiments.
* denotes P < 0.05, ** denotes P < 0.01; one-way ANOVA was used for statistical analysis. (C) Confocal micrographs of keratinocytes treated with 5 μg/ml of ﬂuorescently
labelled LecB (pink) and stained for LC3 (red) and IGF-1R (green). Panel indicated as “+LecB” refers to 12 h incubation. White arrows point at colocalisation among LecB,
LC3, and IGF-1R. Scale bar: 10 μm. N = 3. (D, E) Representative images of NHKs treated with LecB and stained for (D) IGF-1R (green), LC3 (red), and (E) TfR (green). Intensity
proﬁles of single cells, along the yellow line are shown. Scale bar: 10 μm.
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and phosphatase inhibitor cocktail 3 (1:100) were from Sigma-Aldrich.
To block LecB binding to the host cell membranes, L-fucose (Sigma-
Aldrich) was used at a concentration of 30 mM. Cycloheximide (20 μg/
ml) and staurosporine (500 nM) were both purchased from Sigma-
Aldrich and used as a protein synthesis inhibitor and as positive
control for cell death, respectively. Baﬁlomycin A1 was from InvivoGen
and used at a concentration of 100 or 200 nM, whereas cytochalasin D
was from Sigma-Aldrich and applied at a concentration of 0.5 μg/ml.
Human IGF-1 was from Thermo Fisher Scientiﬁc and used as an IGF-1
receptor activator.
Cell culture
NHKs, kindly provided by D Kiritsi (Department of Dermatology),
were grown at 37°C and in the presence of 5% CO2 in keratinocyte
medium supplemented with bovine pituitary extract, epidermal
growth factor, and 0.5% penicillin/streptomycin. Cells were seeded
24 h before each experiment. If not stated differently, all treatments
were performed in complete medium.
LecB production and in vitro labelling
Recombinant LecB (UniProt ID: Q9HYN5_PSEAE) was produced from
Escherichia coli BL21(DE3) containing pET25pa21 and puriﬁed via
chromatography using a mannose-agarose column as previously
described (Mitchell et al, 2002); Chemani et al, 2009). The eluate was
dialysed in water for 7 d and ﬁnally lyophilised. The obtained
powder was dissolved in PBS (138 mM NaCl, 2.7 mM KCl, 8 mM
Na2HPO4, and 1.5 mM KH2PO4, pH 7.4) and sterile-ﬁltered. In ad-
dition, to exclude endotoxin contamination, LecB was further pu-
riﬁed using an endotoxin removal column (Hyglos) and an LAL
chromogenic endotoxin quantitation kit (Thermo Fisher Scientiﬁc)
was carried out. The purity of the lectin was conﬁrmed by SDS–PAGE.
If not stated differently, LecB was used at a ﬁnal concentration of
5 μg/ml (106 nM).
LecB was ﬂuorescently labelled using Cy3 (GE Healthcare) or
Alexa Fluor488 (Thermo Fisher Scientiﬁc) monoreactive NHS ester
and puriﬁed using Zeba Spin desalting columns (Thermo Fisher
Scientiﬁc) according to the manufacturers’ instructions.
Biotinylated LecB was obtained using sulfo-NHS-SS-Biotin (Thermo
Fisher Scientiﬁc) according to the supplier’s instructions and dialysed
two times for 1 h in water and one time overnight in PBS.
Gene silencing
Cells were incubated with a mix of siRNA against ATG13 (Dharmacon)
and transfection reagent (Dharmacon) for 5–6 h. 24 h post-transfection
lysates were checked for silencing efﬁciency. LecB stimulation was
performed 36 h post-silencing. A control siRNA (Santa Cruz) was used
to evaluate off-target effects.
Mass spectrometry analyses
Cells were seeded in T-75 ﬂasks and stimulated with biotinylated
LecB at a concentration of 5 μg/ml. Upon treatment, the cells were
washed in PBS and lysed with 50 mM Tris–HCL, pH 7.5, 150 mM
sodium chloride, 1% (vol/vol) IGEPAL CA-630, and 0.5% (wt/vol)
sodium deoxycholate in water. The protein lysates were incubated
overnight at 4°C with streptavidin agarose beads (Thermo Fisher
Scientiﬁc) to precipitate LecB–biotin–protein complexes. The beads
were washed four times in PBS and then resuspended in 8 M urea.
Immunoprecipitates were predigested with LysC (1:50, w/w) fol-
lowed by the reduction of disulﬁde bonds with 10 mM DTT and
subsequent alkylation with 50 mM iodacetamide. Then samples
were diluted 1:5 with ammonium bicarbonate buffer, pH 8, and
trypsin (1:50, w/w) was added for overnight digestion at RT. The
resulting peptide mixtures were acidiﬁed and loaded on C18
StageTips (Rappsilber et al, 2007). Peptides were eluted with 80%
acetonitrile (ACN), dried using a SpeedVac centrifuge, and resus-
pended in 2% ACN, 0.1% TFA, and 0.5% acetic acid.
Peptides were separated on an EASY-nLC 1200 HPLC system
(Thermo Fisher Scientiﬁc) coupled online to a Q Exactive HF mass
spectrometer via a nanoelectrospray source (Thermo Fisher Sci-
entiﬁc). Peptides were loaded in buffer A (0.5% formic acid) on in-
house–packed columns (75-μm inner diameter, 50-cm length, and
1.9-μm C18 particles from Dr. Maisch GmbH). Peptides were eluted
with a nonlinear 270-min gradient of 5–60% buffer B (80% ACN, 0.5%
formic acid) at a ﬂow rate of 250 nl/min and a column temperature
of 50°C. The Q Exactive HF was operated in a data-dependent mode
with a survey scan range of 300–1,750m/z and a resolution of 60,000
at m/z 200. MaxQuant software (version 1.5.3.54) was used to an-
alyse MS raw ﬁles (Cox & Mann, 2008). MS/MS spectra were
searched against the human ProteomeUniProt FASTA database and
a common contaminants database (247 entries) by the Andromeda
search engine (Cox et al, 2011).
Immunoﬂuorescence and confocal microscopy
Between 4 and 5 × 104 cells were seeded on 12-mm glass cover slips
in a 24-well plate and cultured for 1 d before the experiment.
Keratinocytes were treated with LecB for the indicated concen-
trations and time points. Surface or whole cell staining was then
performed. For surface staining, NHKs were ﬁxed with 4% (wt/vol)
formaldehyde (FA) for 10min and quenched with 50mM ammonium
chloride for 5 min. The cells were blocked with 3% (wt/vol) of BSA in
PBS and incubated overnight with the primary antibody diluted in
blocking solution (see the details for the used antibodies in Table
S2). The cells were then washed in PBS and incubated for 30 min
with the dye-labelled secondary antibody. For whole cell staining,
the cells were ﬁxed with 4% (wt/vol) FA and quenched, as pre-
viously described. When methanol ﬁxation was used instead of FA,
the cells were incubated with ice cold methanol for 10 min and
rinsed twice with PBS. After ﬁxation, 10 min incubation with 0.1%
(vol/vol) Triton X-100 in PBS was performed. The cells were blocked
and subsequently stained with the primary and secondary anti-
body, as previously described, but using blocking solution sup-
plemented with 0.05% Triton X-100.
Nuclei were additionally stained with DAPI diluted in PBS with
0.1% (vol/vol) Triton X-100. After three additional washes, glass
cover slips were mounted with Mowiol and imaged using an A1R
Nikon confocal microscopy system with a 60× oil immersion ob-
jective (NA = 1.49). Z-stacks of at least three different areas per
condition were acquired and analysed with Fiji ImageJ 1.0 software.
Coloc2 Fiji’s plugin was used for colocalisation analysis.
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Western blot analyses
NHKs were seeded in a 12-well plate at a density of 1.3 × 105 per well
and stimulated with LecB for the indicated time points. After the
treatment, the cells were washed with PBS and lysed in RIPA buffer
(20 mM Tris–HCl, pH 8, 0.1% [wt/vol] SDS, 10% [vol/vol] glycerol, 13.7
mM NaCl, 2 mM EDTA, and 0.5% [wt/vol] sodium deoxycholate) in
water supplemented with protease and phosphatase inhibitors.
Protein concentration was measured using bicinchoninic acid
assay assay kit (Thermo Fisher Scientiﬁc) and normalised. The
samples were then separated via SDS–PAGE and subsequently
transferred onto a nitrocellulose membrane. Membranes were
blocked in 3% (wt/vol) BSA or 5% (wt/vol) milk powder in TBS
supplemented with 0.1% (vol/vol) Tween 20 and incubated with the
primary and horseradish peroxidase secondary antibodies in
blocking solution (see antibody list in Table S2).
Protein bands were visualised via chemiluminescence reaction
using the Fusion-FX7 Advance imaging system (Peqlab Bio-
technology). A densitometric analysis of at least three independent
experiments was carried out using FIJI ImageJ 1.0 software.
Cell viability assays
To assess cytotoxicity and morphological changes upon treatment
with LecB, NHKs were seeded in a 24-well plate at a density of 5 × 104
per well and treated for 24 h with different LecB concentrations ±
fucose (30 mM). Images were acquired using Evos FL Cell Imaging
Systems (Thermo Fisher Scientiﬁc) using 20× objective (NA = 0.45).
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
tetrazolium reduction assay kit (Merck) was additionally used to
quantify cell viability upon LecB treatment. For this purpose, cells were
grown into a 96-well plate and stimulated for 24 h with the indicated
LecB concentrations ± L-fucose. The MTT solution was added for 4 h at
37°C with 5% CO2 and the absorbance at 570 nm was measured.
Ultrastructural analyses
For conventional transmission electron microscopy, NHKs were
treated or not with 5 μg/ml of LecB, for the indicated time periods.
An equal volume of double-strength ﬁxative (4% paraformaldehyde
and 4% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4)
was then added to the cells for 20 min at room temperature before
ﬁxing the cells with one volume of single-strength ﬁxative (2%
paraformaldehyde and 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer, pH 7.4) for 2 h at room temperature. After washes
with cacodylate buffer (pH 7.4), the cells were then scraped and
embedded as previously described (Verheije et al, 2008). Ultrathin
70-nm sections were cut using a Leica EM UC7 ultra microtome
(Leica Microsystems) and stained with uranyl acetate and lead
citrate as previously described (Verheije et al, 2008).
For the IEM analyses, NHKs were treated for 12 h with biotinylated
LecB and ﬁxed by addition of 4% PFA and 0.4% glutaraldehyde in 0.1
M phosphate buffer (pH 7.4) in an equal volume to the DMEM
medium, before to be incubated for 20 min at room temperature.
The cells were subsequently ﬁxed in 2% PFA and 0.2% glutaral-
dehyde in 0.1 M phosphate buffer (pH 7.4) for 3 h at room tem-
perature and then embedded for the Tokuyasu procedure before
cutting into ultrathin cryosections and labelling them with immu-
nogold, as previously described (Slot and Geuze, 2007). Biotinylated
LecB was detected using an anti-biotin rabbit antibody (100-4198;
Rockland). The labelling was revealed with protein A conjugated with
10 nm gold (CMC). As labelling control, NHKs were incubated with
non-biotinylated LecB. No immunogold labelling was detected in this
sample. The cell sections were analysed using a CM100 Bio TEM (FEI).
Immunoﬂuorescence of chronic human wounds
Fixed sections of human chronic wounds were kindly provided by D
Kiritsi (Department of Dermatology, Medical Centre, Albert Ludwigs
University, Freiburg). Antigens were retrieved with 0.05% pronase
(Sigma-Aldrich). Sections were blocked with 3% (wt/vol) BSA in PBS
and probed overnight with an anti-LecB or anti-P. aeruginosa an-
tibody. After two washing steps with PBS supplemented with 0.1%
Tween 20, the sections were stained with a dye-labelled secondary
antibody, counterstained with DAPI, and mounted in ﬂuorescence
mounting medium (Dako). Images were acquired using Zeiss Axio
Imager A1 ﬂuorescence microscopy.
Statistics
All data were obtained from at least three independent experi-
ments and are shown as the means ± SEM.
Statistical analysis was performed using GraphPad Prism soft-
ware. One-way or two-way ANOVA were chosen to assess signiﬁ-
cance in experiments with multiple conditions. Otherwise, when
experimental data for one condition were compared with the
relative control condition, multiple t test was applied.
A P-value < 0.05 was considered as statistically signiﬁcant.
* denotes P < 0.05; ** denotes P < 0.01; *** denotes P < 0.001; ****
denotes P < 0.0001; ns denotes not signiﬁcant.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201900422.
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